Oral-Systemic Link: Page 87

2-drug combo may slow thyroid cancer
By DrBicuspid.com staff writers
A combination of the drugs pazopanib and paclitaxel shows promise in slowing anaplastic thyroid cancer, according to a new study in Science Translational Medicine (January 2, 2013, Vol. 5:166, p. 166ra3).
January 9, 2013
Quest divests OralDNA Labs
By DrBicuspid.com staff writers
Quest Diagnostics has sold substantially all the assets of its OralDNA Labs salivary diagnostics business to Access Genetics, a clinical laboratory with advanced molecular diagnostics test development and information technology capabilities.
January 8, 2013
Study finds persistent oral bacteria after ECC treatment
By DrBicuspid.com staff writers
In a follow-up to a study conducted one year ago, researchers at the Oregon Health & Science University (OHSU) School of Dentistry have determined that certain genetic strains of bacteria are dominant in children one year after treatment for microbial-caused plaque and tooth decay.
January 7, 2013
Oral CDx developer merges with licensee
By DrBicuspid.com staff writers
Oral Cancer Prevention International and CDx Laboratories have combined forces as CDx Diagnostics.
January 7, 2013
HPV-related cancers on the rise
By DrBicuspid.com staff writers
The rising incidence of cancers associated with human papillomavirus (HPV) shows a need to increase HPV vaccination coverage levels, according to a report in the Journal of the National Cancer Institute.
January 7, 2013
NIH grant funds NYU diabetes screening research
By DrBicuspid.com staff writers
The National Institutes of Health (NIH) has awarded Shiela Strauss, PhD, a professor of nursing at the New York University Colleges of Nursing and Dentistry, a two-year, $336,433 grant to study diabetes screening in dental patients.
January 7, 2013
Gingivitis bacteria manipulates immune system
By DrBicuspid.com staff writers
A new study highlights the mechanism by which Porphyromonas gingivalis establishes a chronic infection in the form of periodontal disease and provides insight into how the disease develops.
January 6, 2013
Study to assess lubricant that stops HPV transmission
By DrBicuspid.com staff writers
A new study at McGill University will test the ability of a personal lubricant with a special form of carrageenan gel to prevent the transmission of human papillomavirus (HPV).
January 6, 2013
Mild sleep apnea may help heart attack patients heal
By DrBicuspid.com staff writers
A new study suggests that some heart attack patients may actually benefit from mild to moderate sleep-disordered breathing such as sleep apnea.
January 2, 2013
Long-term study supports periodontitis/diabetes link
By Kathy Kincade
The scientific evidence linking type 2 diabetes with a significantly greater risk of periodontitis continues to mount, according to a new study in Diabetes Research and Clinical Practice. In addition, individuals with diabetes may be at increased risk of tooth loss.
January 1, 2013
2009 12 18 17 14 51 672 Diabetes Thumb 1
Reolysin may aid head/neck cancer chemo patients
By DrBicuspid.com staff writers
Reolysin, a drug developed by Oncolytics Biotech to boost the effects of standard chemotherapy drugs, has shown initial positive results in a clinical study of patients with head and neck cancer.
December 30, 2012
New research reveals genetic mutations of head/neck cancer
By DrBicuspid.com staff writers
New findings regarding the genetic mutations that cause head and neck cancer may lead to new therapies, according to collaborative research presented in November at the 2012 Chemotherapy Foundation Symposium in New York City.
December 25, 2012
Previous Page
Page 87 of 153
Next Page